HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.

Abstract
The biochemical effects of the 2-nitroimidazole hypoxic cell radiosensitizers KIN-804, KIN-806, and their analogues KIN-844 and TX-1877 on brain acetylcholinesterase (AChE) and hepatic free radical scavenging systems, such as reduced glutathione (GSH) and glucose-6-phosphate dehydrogenase (G-6-PDH) levels, and hepatic antioxidants, such as superoxide dismutase (SOD) and catalase, were evaluated in Ehrlich ascites carcinoma (EAC)-bearing Swiss albino mice. The assay of brain AChE revealed nonsignificant changes with all drugs examined. To evaluate the hepatic metabolic capacity, groups of mice were divided into control, EAC-inoculated, 10-Gy local gamma-irradiated, and KIN-804, KIN-844, KIN-806, or TX-1877 (50 mg/kg body weight, i.p.) groups, and gamma-irradiation was combined with each drug. EAC inoculation markedly suppressed GSH, G-6-PDH, SOD, and catalase levels. On the other hand, treatment with gamma-irradiation significantly enhanced them. The treatment of EAC-bearing mice with each drug alone in the absence of gamma-irradiation revealed that KIN-806 and its derivative TX-1877 showed antitumor activity through their significant recovery of GSH and SOD levels, respectively, in the EAC-bearing mice group. Similarly, the combined treatment of EAC-bearing mice with gamma-irradiation with each of the drugs tested showed that KIN-806 and TX-1877 significantly increased GSH and SOD, and to a lesser extent G-6-PDH and catalase levels. On the other hand, KIN-804 and KIN-844 had only a nonsignificant effect on all parameters examined. In conclusion, these data reveal that the administration of KIN-806 and TX-1877 with or without subsequent gamma-irradiation, resulted in significant recovery of GSH and SOD activities that were inhibited by EAC inoculation.
AuthorsFarid Ahmed Abou-Bedair, Hitoshi Hori, Hideko Nagasawa, Yoshihiro Uto, Medhat Abu-Zeid, Seiichi Inayama
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 25 Issue 5 Pg. 591-6 (May 2002) ISSN: 0918-6158 [Print] Japan
PMID12033498 (Publication Type: Journal Article)
Chemical References
  • 2-nitroimidazole acetamide
  • Free Radical Scavengers
  • Hydroxamic Acids
  • KIN 806
  • KIN 844
  • Nitroimidazoles
  • Radiation-Sensitizing Agents
  • 2-nitroimidazole-1-methylacetohydroxamate
  • Glucosephosphate Dehydrogenase
  • Catalase
  • Superoxide Dismutase
  • Acetylcholinesterase
  • Glutathione
Topics
  • Acetylcholinesterase (metabolism)
  • Animals
  • Brain Chemistry (drug effects)
  • Carcinoma, Ehrlich Tumor (metabolism)
  • Catalase (metabolism)
  • Cell Hypoxia (drug effects)
  • Female
  • Free Radical Scavengers (metabolism)
  • Glucosephosphate Dehydrogenase (metabolism)
  • Glutathione (metabolism)
  • Hydroxamic Acids (pharmacology)
  • Liver (drug effects, metabolism)
  • Mice
  • Nitroimidazoles (pharmacology)
  • Radiation-Sensitizing Agents (pharmacology)
  • Superoxide Dismutase (metabolism)
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: